Design Therapeutics, Inc. (DSGN)
NASDAQ: DSGN · Real-Time Price · USD
4.076
+0.106 (2.68%)
Aug 8, 2025, 11:28 AM - Market open
Apartment Income REIT Market Cap
Design Therapeutics has a market cap or net worth of $231.41 million as of August 8, 2025. Its market cap has increased by 1.14% in one year.
Market Cap
231.41M
Enterprise Value
16.73M
1-Year Change
1.14%
Ranking
Category
Stock Price
$4.08
Market Cap Chart
Since the IPO on March 26, 2021, Design Therapeutics's market cap has decreased from $2.21B to $231.41M, a decrease of -89.51%. That is a compound annual growth rate of -40.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2025 | 225.37M | -35.49% |
| Dec 31, 2024 | 349.35M | 135.41% |
| Dec 29, 2023 | 148.40M | -74.10% |
| Dec 30, 2022 | 572.92M | -51.55% |
| Dec 31, 2021 | 1.18B | -46.40% |
| Mar 26, 2021 | 2.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 575.32B |
| Johnson & Johnson | 413.10B |
| AbbVie | 351.30B |
| Abbott Laboratories | 229.85B |
| AstraZeneca | 227.78B |
| UnitedHealth Group | 221.95B |
| Novartis AG | 221.76B |
| Novo Nordisk | 213.92B |